Vivos Therapeutics (VVOS) Other Non Operating Income (2021 - 2026)
Vivos Therapeutics (VVOS) posted quarterly Other Non Operating Income of -$1.2 million for Q1 2026, down 29075.0% year-over-year from N/an in Q1 2025, and down 84.94% quarter-over-quarter from -$631000.0 in Q4 2025.
Vivos Therapeutics (VVOS) Other Non Operating Income (2021 - 2026) Analysis & Trends
Vivos Therapeutics (VVOS) has reported Other Non Operating Income for 6 consecutive years, with -$1.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Non Operating Income fell 29075.0% year-over-year to -$1.2 million; the TTM figure through Mar 2026 stood at -$2.6 million (down 2257.14% YoY), while the FY2025 annual figure was -$1.5 million, down 1246.36% from the prior year.
- Other Non Operating Income slipped to -$1.2 million in Q1 2026 per VVOS's latest filing, from -$631000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $51000.0 in Q1 2023 and bottomed at -$1.2 million in Q1 2026.
- Historically, Other Non Operating Income has averaged -$184882.4 across 5 years, with a median of -$38000.0 in 2022.
- Annual changes were most pronounced in 2023 — Other Non Operating Income surged 234.21% — and 2026, when it tumbled 29075.0%.
- Vivos Therapeutics' Other Non Operating Income stood at -$38000.0 in 2022, then soared by 63.16% to -$14000.0 in 2023, then sank by 385.71% to -$68000.0 in 2024, then plunged by 827.94% to -$631000.0 in 2025, then tumbled by 84.94% to -$1.2 million in 2026.
- Business Quant data shows VVOS's Other Non Operating Income at -$1.2 million in Q1 2026, -$631000.0 in Q4 2025, and -$679000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | Vivos Therapeutics | 5.18 Mn | 3.38 Mn | 2.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.17 Mn |
| Dec 31, 2025 | -631,000.00 |
| Sep 30, 2025 | -679,000.00 |
| Jun 30, 2025 | -163,000.00 |
| Mar 31, 2025 | -4,000.00 |
| Dec 31, 2024 | -68,000.00 |
| Sep 30, 2024 | -18,000.00 |
| Jun 30, 2024 | -22,000.00 |
| Mar 31, 2024 | -1,000.00 |
| Dec 31, 2023 | -14,000.00 |
| Sep 30, 2023 | -53,000.00 |
| Jun 30, 2023 | -225,000.00 |
| Mar 31, 2023 | 51,000.00 |
| Dec 31, 2022 | -38,000.00 |
| Sep 30, 2022 | -36,000.00 |
| Jun 30, 2022 | -37,000.00 |
| Mar 31, 2022 | -38,000.00 |
| Dec 31, 2021 | -95,000.00 |
| Sep 30, 2021 | 59,000.00 |
| Jun 30, 2021 | 19,000.00 |